Pyridostigmine, diethyltoluamide, permethrin, and stress: A double-blind, randomized, placebo-controlled trial to assess safety

Mayo Clinic Proceedings

Volumn 81, Issue 10, 2006, Pages 1303-1310

  Roy, Michael J ^a   Kraus, Patricia L ^a   Seegers, Cynthia A ^a,d   Young, Sylvia Y N ^b   Kamens, Deborah R ^a   Law, Wendy A ^a   Cherstniakova, Svetlana A ^a   Chang, David N ^c   Cooper, Jamie A ^a,e   Sato, Paul A ^b   Matulich, William ^b,f   Krantz, David S ^b   Cantilena, Louis R ^a   Deuster, Patricia A ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c Epistat   (United States)

^d Naval Operational Medicine Institute   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f St Vincent de Paul Village   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLTOLUAMIDE; PERMETHRIN; PLACEBO; PYRIDOSTIGMINE;

ADULT; ARTICLE; BLOOD LEVEL; CLIMBING; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXPOSURE; FEMALE; GRIP STRENGTH; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTOXICITY; NORMAL HUMAN; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REST; SELF REPORT; STRESS; SYSTOLIC BLOOD PRESSURE;

EID: 33749257995     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.10.1303     Document Type: Article

References (30)

1. Dunn MA, Hackley BE Jr, Sidell FR. Pretreatment for nerve agent exposure. In: Sidell FR, Takafuji ET, Franz DR, eds. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Borden Institute, Walter Reed Army Medical Center; 1997:181-196.
2. Keeler JR, Hurst CG, Dunn MA. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA. 1991;266:693-695.
3. Cook JE, Kolka MA, Wenger CB. Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment. Mil Med. 1992;157:250-254.
4. Schiflett SG, Stranges SF, Slater T, Jackson MK. Interactive effects of pyridostigmine and altitude on performance. In: Proceedings of the Sixth Medical Chemical Defense Bioscience Review. Aberdeen Proving Ground, Md: US Army Medical Research Institute of Chemical Defense; 1987:605-607.
5. Schiflett SG, Miller JC, Gawron VJ. Pyridostigmine bromide effects of performance of tactical transport aircrews. In: Proceedings of the Sixth Medical Chemical Defense Bioscience Review. Aberdeen Proving Ground, Md: US Army Medical Research Institute of Chemical Defense; 1987:609-611.
6. Gall D. The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundam Appl Toxicol. 1981;1:214-216.
7. Glickson M, Achiron A, Ram Z, et al. The influence of pyridostigmine administration on human neuromuscular functions-studies in healthy human subjects. Fundam Appl Toxicol. 1991;16:288-298.
8. Roach JM, Eliasson AH, Phillips YY. The effect of pyridostigmine on bronchial hyperreactivity. Chest. 1993;103:1755-1758.
9. Golomb BA. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses. Vol 2: Pyridostigmine Bromide. Santa Monica, Calif: RAND; 1999.
10. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med. 1996;2:1382-1385.
11. Grauer E, Alkalai D, Kapon J, Cohen G, Raveh L. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol Appl Pharmacol. 2000;164:301-304.
12. Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Abdel-Rahman A, Bullman SL, Khan WA. Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. Pharmacol Biochem Behav. 2004;77:253-262.
13. Iowa Persian Gulf Study Group. Self-reported illness and health status among Gulf War veterans: a population-based study. JAMA. 1997;277:238-245.
14. Centers for Disease Control and Prevention. Unexplained illness among Persian Gulf War veterans in an Air National Guard unit: preliminary report-August 1990-March 1995. MMWA Morb Mortal Wkly Rep. 1995;44:443-447.
15. Kroenke K, Koslowe P, Roy M. Symptoms in 18,495 Persian Gulf War veterans: latency of onset and lack of association with self-reported exposures. J Occup Environ Med. 1998;40:520-528.
16. Hyams KC, Wignall FS, Roswell R. War syndromes and their evaluation: from the U.S. Civil War to the Persian Gulf War. Ann Intern Med. 1996; 125:398-405.
17. Sartin JS. Gulf War illnesses: causes and controversies. Mayo Clin Proc. 2000;75:811-819.
18. Riddle JR, Hyams KC, Murphy FM, Mazzuchi JF. In the borderland between health and disease following the Gulf War. Mayo Clin Proc. 2000;75:777-779.
19. Bolton HT. Use and safety of pesticides (repellents) in Persian Gulf. Presented at: Department of Veterans Affairs Update on Health Consequences of Persian Gulf Service: Baltimore, Md; July 18, 1995.
20. Robbins PJ, Cherniack MG. Review of the biodistribution and toxicity of the insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health. 1986;18:503-525.
21. Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol. 1996;132:901-905.
22. Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War: a cross-sectional epidemiologic study. JAMA. 1997;277:231-237.
23. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin. J Toxicol Environ Health. 1996;48:35-56.
24. McCain WC, Lee R, Johnson MS, et al. Acute oral toxicity study of pyridostigmine bromide, permethrin, and DEET in the laboratory rat. J Toxicol Environ Health. 1997;50:113-124.
25. Roy MJ, Kraus PL, Cooper JA, et al. Initial evaluation of N,N-diethl-m-toluamide and permethrin absorption in human volunteers under stress conditions. Mil Med. 2006;171:122-127.
26. Armed Forces Pest Management Board Repellents Committee. Personal Protective Measures Against Insects and Other Arthropods of Military Significance. Washington, DC: Defense Pest Management Information Analysis Center, Forest Glen Section, Walter Reed Army Medical Center; 1996. Technical Guide No. 36.
27. Krantz DS, Manuck SB. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. Psychol Bull. 1984;96:435-464.
28. Reeves DL, Winter KP, LaCour SJ, et al. Automated Neuropsychological Assessment Metrics Documentation. Vol. 1: Test Administration Guide. Silver Spring, Md: Office of Military Performance Assessment Technology; 1992.
29. Abou-Donia MB, Wilmarth KR, Abdel-Rahman AA, Jensen KF, Oehme FW, Kurt TL. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam Appl Toxicol. 1996;34: 201-222.
30. Hong JS, Herr DW, Hudson PM, Tilson HA. Neurochemical effects of DDT in rat brain in vivo. Arch Toxicol Suppl. 1986;9:14-26.